• Mashup Score: 0

    July 12, 2023 — CPR Therapeutics Inc. (CPR-T), a Vermont-based medical device start-up company, announced today that it has received three U.S. patents for inventions that will contribute to the development of their breakthrough technology for cardiopulmonary resuscitation. The first patent (US11,684,542) is for CPR devices that use more than one type of compression pattern to increase blood flow…

    Tweet Tweets with this article
    • @DAICeditor #CPRTherapeutics Inc. announced that it has received three U.S. #patents for #inventions that will contribute to the development of their #breakthrough #technology for #cardiopulmonary #resuscitation: https://t.co/TlZub69umv

  • Mashup Score: 0

    WASHINGTON — Patients who experienced a COPD exacerbation had a greater risk for acute cardiovascular events than patients who did not, according to a presentation at the American Thoracic Society International Conference.These presented data were part of the retrospective cohort study EXACOS-CV US, which, along with the EROS study, was one of two notable AstraZeneca-funded studies

    Tweet Tweets with this article
    • #ATS2023: “Patients with #COPD should be considered at risk of #cardiopulmonary events, including stroke, heart failure, pulmonary embolism, arrhythmia or heart attack, following an acute #exacerbation,” Charlie Strange, MD, at @MedUnivSC, told Healio. https://t.co/g6ndkmiKEE